VRY-11877-26997
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 947 / CA
- Registered
- 2021-03-26
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-26
Registered in v-safe
-
2021-03-26
Survey response — day 7, dose 1MedDRA: Unevaluable event — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: 14 weeks pregnant, had spotting 3/22-3/24. Otherwise healthy pregnancy.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-26
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-01
- 2021-04-07
-
2021-04-08
Survey response — day 21, dose 1MedDRA: Haemorrhage in pregnancy, Pregnancy — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Spotting, 15-16 weeks pregnantMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-08
Report sent to call center — day 21, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-04-09
-
2021-04-13
Dose 2 — Pfizer-BioNTech
- 2021-04-13
-
2021-04-14
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-15
- 2021-04-19
- 2021-04-27
- 2021-05-04
- 2021-05-18
- 2021-05-25
-
2021-07-13
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Cold, upper respiratory infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-07-13
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-07-26
- 2021-10-12
- 2022-04-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-13 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-03-26 | Unsuccessful | |
| 2021-04-08 | Unsuccessful | |
| 2021-07-13 | Unsuccessful |
Free text
Release 6 — day 7, dose 1
Systemic reaction (other): 14 weeks pregnant, had spotting 3/22-3/24. Otherwise healthy pregnancy.
Release 7 — day 21, dose 1
Symptoms: Spotting, 15-16 weeks pregnant
Release 9 — 3 months, dose 2
Symptoms: Cold, upper respiratory infection
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Haemorrhage in pregnancy | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Pregnancy | ✓ | ✓ | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release